… SARS-CoV-2 existed in tears and conjunctival secretions in NCP patients with
conjunctivitis. … The present study assessed the tears and conjunctival secretions in SARS-CoV-2-infected …

… the presence of SARS-CoV-2 RNA in tears and conjunctival secretions has been … of
SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients with and without conjunctivitis to …

… conjunctival swabs for SARS-CoV-2 over a period of 5 days until day 18 of his illness [9].
Similarly, in a case from Italy, SARS-CoV-2 RNA was detected in conjunctival secretions … virus …

… the tear and conjunctival secretions of COVID-19 patients … virus in tears and conjunctival
secretions is important for understanding the potential diverse transmission routes for this virus. …

… In our study, we identified SARS-CoV-2 RNA shedding in the conjunctival secretions of 4
of 49 (8.2%) patients without ocular symptoms. The apparently higher rate in this study than in …

… , 2 SARS‐CoV‐2 in tears and conjunctival secretions may come from the secretion of lacrimal
glands and conjunctival epithelial cells, or even fomites transmitted onto ocular surface via …

… SARS-CoV-2 may use ocular structure as an additional transmission route, as … patients’
conjunctival secretion and tears positivity to reverse transcriptase-PCR SARS-CoV-2-RNA assay. …

… , SARS-CoV-2 RNA was detected in conjunctival secretions collected from the only patient
with conjunctivitis … to evaluate the infectious potential of the SARS-CoV-2 RNA detected in the …

… Considering that SARS-CoV-2 is present in tears and conjunctival secretions, external ocular
infections could be factors of infectious spreading. Physicians should be aware of late (>2 …

… hyperemia has been said to be more prominent, and conjunctival discharge less so in the
early … current study was mild conjunctival hyperemia and watery discharge. Other than artificial …